Rani Therapeutics (RANI)
(Delayed Data from NSDQ)
$6.31 USD
-0.47 (-6.93%)
Updated May 10, 2024 04:00 PM ET
After-Market: $6.32 +0.01 (0.16%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Rani Therapeutics Holdings, Inc. [RANI]
Reports for Purchase
Showing records 41 - 43 ( 43 total )
Company: Rani Therapeutics Holdings, Inc.
Industry: Medical - Biomedical and Genetics
E.N.D.O - Exploring New Drug Opportunities in Endocrinology KOL Call Highlights
Provider: Wedbush Securities Inc.
Analyst: ARGYRIDES A
Company: Rani Therapeutics Holdings, Inc.
Industry: Medical - Biomedical and Genetics
Eureka! Making Oral Biologics a Reality with RaniPill; Initiating OP & $28 PT
Provider: Wedbush Securities Inc.
Analyst: ARGYRIDES A